Krapov,
your mail is spot on to what my source is reflecting - I have now double checked this.
Redundancy's were already put on the table last friday.
Julian Chick (CEO) is going (as are other senior execs and staff.
My source indicates the likely scenario for ATC will now be to consolidate finances and rely on potential M&A to keep the program alive. The money the company has in the bank will be the attraction for a potential suitor to execute the transaction.
Expect certain Aust biotechs to make a play??
Add to My Watchlist
What is My Watchlist?